Skip to main content

ADVERTISEMENT

myelodysplastic syndrome

News
12/03/2020
Journal of Clinical Pathways
Research in Review
11/28/2016
JCP Editors
Patients with acute myeloid leukemia (AML) whose cells carry TP53 mutations may survive longer if they are treated with decitabine, according to a recent study in The New England Journal of...
Patients with acute myeloid leukemia (AML) whose cells carry TP53 mutations may survive longer if they are treated with decitabine, according to a recent study in The New England Journal of...
...
11/28/2016
Journal of Clinical Pathways